← Back to the feed

RICB DIAGNOSTICS AG

History from 24 Jun 2022

UID

CHE-274.461.895

Legal form

AG

Canton

SG

Founded

24 Jun 2022

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 30 Jun 2022 · legal date 24 Jun 2022

   Company formed

   Founded 24 Jun 2022

   SHAB HR01-1005508827 ↗

2. SHAB published 28 Oct 2024 · legal date 30 Sep 2024

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   100’000 → 119’999.80

   Shares

   1’000’000 → 1’199’998

   New shares, % of post-step shares

   16.7% (199’998 new)

   Aktienkapital neu: CHF 119'999.80 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 119'999.80 [bisher: CHF 100'000.00]. Aktien neu: 1'199'998 Namenaktien zu CHF 0.10 [bisher: 1'000'000 Namenaktien zu CHF 0.10]. Die Gesellschaft hat mit Beschluss vom 30.09.2024 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.

   SHAB HR02-1006164169 ↗

3. SHAB published 28 Oct 2024 · legal date 30 Sep 2024

   Capital band adopted

   SHAB HR02-1006164169 ↗

4. SHAB published 1 Oct 2025 · legal date 24 Sep 2025

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   119’999.80 → 139’999.60

   Shares

   1’199’998 → 1’399’996

   New shares, % of post-step shares

   14.3% (199’998 new)

   Aktienkapital neu: CHF 139'999.60 [bisher: CHF 119'999.80]. Liberierung Aktienkapital neu: CHF 139'999.60 [bisher: CHF 119'999.80]. Aktien neu: 1'399'996 Namenaktien zu CHF 0.10 [bisher: 1'199'998 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb Kapitalband.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006446743 ↗

5. SHAB published 11 Mar 2026 · legal date 26 Feb 2026

   Capital band adopted

   SHAB HR02-1006593080 ↗

6. SHAB published 4 May 2026 · legal date 20 Apr 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   139’999.60 → 156’082.40

   Shares

   1’399’996 → 1’560’824

   New shares, % of post-step shares

   10.3% (160’828 new)

   Aktienkapital neu: CHF 156'082.40 [bisher: CHF 139'999.60]. Liberierung Aktienkapital neu: CHF 156'082.40 [bisher: CHF 139'999.60]. Aktien neu: 1'560'824 Namenaktien zu CHF 0.10 [bisher: 1'399'996 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb Kapitalband.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006641964 ↗

Published by 10 May 2026

Latest available record · 8 Oct 2026